More Imugene Ltd news
Imugene LtdASX: IMU

Cancer vaccine shows early promise in clinical trial

Feb 6, 2018 at 10:34 PM EST · Issued by Imugene Ltd

Filed with ASX · Feb 6, 2018 at 10:34 PM EST · 2 pages · English

On 6ix: 6ix.com/news/cancer-vaccine-shows-early-promise-in-clinical-trial

Imugene Ltd on 6ix

Earlier from Imugene

  • Business Update - December Quarter Appendix 4CJan 28, 2018
  • Rights Issue Results & Shortfall NotificationDec 19, 2017
  • Imugene raises $8.7 millionNov 22, 2017
  • Response to ASX Price QueryOct 16, 2017
  • IMU Receives $1.1m R&D Tax RefundOct 10, 2017

Later from Imugene

  • IMU Meets Investigator for Gastric Cancer Clinical TrialFeb 8, 2018
  • Novel Anti-PD-1 Mimotope Vaccine Ready for DevelopmentFeb 11, 2018
  • Arginine Modulator Active in Cancer ModelsFeb 18, 2018
  • Leslie Chong Appointed as Managing DirectorMar 27, 2018
  • Imugene Licences Extensive B-Cell Immuno-Oncology PortfolioJun 6, 2018
All Imugene news releases↗

Follow Imugene into a list and get an email when it puts out news.

Follow Imugene
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer